Abbott (ABT) Q3 2024 Earnings
Abbott reported Q3 2024 revenue of $10.6B, beat analyst consensus of $10.6B by $84.4M. Diluted EPS came in at $1.21, beat the $1.20 consensus by $0.01. Abbott reports across 4 business segments, led by Medical Devices, Established Pharmaceutical Products, and Diagnostic Products.
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Abbott's Q3 2024 earnings report.
Abbott (ABT) reported Q3 2024 earnings on October 16, 2024 before market open.
Abbott reported revenue of $10.6B and diluted EPS of $1.21 for Q3 2024.
Revenue beat the consensus estimate of $10.6B by $84.4M. EPS beat the consensus estimate of $1.20 by $0.01.
You can read the 10-Q periodic report (0001628280-24-044602) directly on SEC EDGAR. The filing index links above go to sec.gov.